Iovance Biotherapeutics Inc
F:2LB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
|
I
|
International Flavors & Fragrances Inc
XMUN:IFF
|
US |
|
S
|
Seabridge Gold Inc
F:SRM
|
CA |
|
Nikkon Holdings Co Ltd
F:1CM
|
JP |
Wall St Price Targets
2LB Price Targets Summary
Iovance Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for 2LB is 4.005 EUR with a low forecast of 1.803 EUR and a high forecast of 6.559 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2LB's stock price target?
Price Target
4.005
EUR
According to Wall Street analysts, the average 1-year price target for 2LB is 4.005 EUR with a low forecast of 1.803 EUR and a high forecast of 6.559 EUR.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Revenue over the next 8 years is 29%.
What is the Gross Profit forecast for Iovance Biotherapeutics Inc?
Projected CAGR
43%
The compound annual growth rate for Gross Profit over the next 8 years is 43%.
